Health-Related Quality of Life after Dengue Fever, Morelos, Mexico, 2016-2017
Annika Schulte, Ingo Weber, Diana Carolina Tiga-Loza, Irma Y Amaya Larios, Donald S Shepard, Cynthia A Tschampl, Eduardo A Undurraga, Ruth A Martínez-Vega, Florian Fischer, Lilia Chihu, Jose Ramos-Castañeda, Annika Schulte, Ingo Weber, Diana Carolina Tiga-Loza, Irma Y Amaya Larios, Donald S Shepard, Cynthia A Tschampl, Eduardo A Undurraga, Ruth A Martínez-Vega, Florian Fischer, Lilia Chihu, Jose Ramos-Castañeda
Abstract
We adapted the EQ-5D-3L questionnaire and visual analog scale to assess health-related quality of life (HRQOL) and persistent symptoms in 79 patients with laboratory-confirmed dengue in Morelos, Mexico. The lowest HRQOLs were 0.53 and 38.1 (febrile phase). Patients recovered baseline HRQOL in ≈2 months.
Keywords: Dengue fever; HRQOL; Mexico; arbovirus infection; arboviruses; burden of disease; dengue virus; economic burden; health status; health-related quality of life; life quality; persistent symptoms; quality of life; vector-borne infections; viruses.
Figures
References
- Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, et al. The global distribution and burden of dengue. Nature. 2013;496:504–7. 10.1038/nature12060
- Shepard DS, Undurraga EA, Halasa YA, Stanaway JD. The global economic burden of dengue: a systematic analysis. Lancet Infect Dis. 2016;16:935–41. 10.1016/S1473-3099(16)00146-8
- Stanaway JD, Shepard DS, Undurraga EA, Halasa YA, Coffeng LE, Brady OJ, et al. The global burden of dengue: an analysis from the Global Burden of Disease Study 2013. Lancet Infect Dis. 2016;16:712–23. 10.1016/S1473-3099(16)00026-8
- Chan M, Kazatchkine M, Lob-Levyt J, Obaid T, Schweizer J, Sidibe M, et al. Meeting the demand for results and accountability: a call for action on health data from eight global health agencies. PLoS Med. 2010;7:e1000223. 10.1371/journal.pmed.1000223
- Hung TM, Clapham HE, Bettis AA, Cuong HQ, Thwaites GE, Wills BA, et al. The estimates of the health and economic burden of dengue in Vietnam. Trends Parasitol. 2018;34:904–18. 10.1016/j.pt.2018.07.007
- Tiga DC, Undurraga EA, Ramos-Castañeda J, Martínez-Vega RA, Tschampl CA, Shepard DS. Persistent symptoms of dengue: estimates of the incremental disease and economic burden in Mexico. Am J Trop Med Hyg. 2016;94:1085–9. 10.4269/ajtmh.15-0896
- Martelli CMT, Nascimento NE, Suaya JA, Siqueira JB Jr, Souza WV, Turchi MD, et al. Quality of life among adults with confirmed dengue in Brazil. Am J Trop Med Hyg. 2011;85:732–8. 10.4269/ajtmh.2011.11-0067
- Lum LCS, Suaya JA, Tan LH, Sah BK, Shepard DS. Quality of life of dengue patients. Am J Trop Med Hyg. 2008;78:862–7. 10.4269/ajtmh.2008.78.862
- World Health Organization. Dengue haemorrhagic fever: diagnosis, treatment, prevention and control. 2nd ed. Geneva: The Organization; 1997.
- EuroQol Group. EuroQol—a new facility for the measurement of health-related quality of life. Health Policy. 1990;16:199–208. 10.1016/0168-8510(90)90421-9
- Zarate V, Kind P, Chuang LH. Hispanic valuation of the EQ-5D health states: a social value set for Latin Americans. Value Health. 2008;11:1170–7. 10.1111/j.1524-4733.2008.00349.x
- Tran BX, Thu Vu G, Hoang Nguyen L, Tuan Le Nguyen A, Thanh Tran T, Thanh Nguyen B, et al. Cost-of-illness and the health-related quality of life of patients in the dengue fever outbreak in Hanoi in 2017. Int J Environ Res Public Health. 2018;15:1174. 10.3390/ijerph15061174
- Suaya JA, Chantha N, Huy R, Sah BK, Moh-Seng C, Socheat D, et al. Clinical characterization, diagnosis and socioeconomic impact of hospitalized dengue in Cambodia [cited 2020 Feb 18].
- Armien B, Suaya JA, Quiroz E, Sah BK, Bayard V, Marchena L, et al. Clinical characteristics and national economic cost of the 2005 dengue epidemic in Panama. Am J Trop Med Hyg. 2008;79:364–71. 10.4269/ajtmh.2008.79.364
- Wu S-JL, Grouard-Vogel G, Sun W, Mascola JR, Brachtel E, Putvatana R, et al. Human skin Langerhans cells are targets of dengue virus infection. Nat Med. 2000;6:816–20. 10.1038/77553
Source: PubMed